REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 154 filers reported holding REATA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $350,000 | -29.0% | 3,483 | 0.0% | 0.06% | -19.2% |
| Q2 2021 | $493,000 | +42.1% | 3,483 | 0.0% | 0.08% | +32.2% |
| Q1 2021 | $347,000 | -19.5% | 3,483 | 0.0% | 0.06% | -20.3% |
| Q4 2020 | $431,000 | +27.1% | 3,483 | 0.0% | 0.07% | +17.5% |
| Q3 2020 | $339,000 | -37.6% | 3,483 | 0.0% | 0.06% | -35.7% |
| Q2 2020 | $543,000 | +8.0% | 3,483 | 0.0% | 0.10% | -10.9% |
| Q1 2020 | $503,000 | -29.4% | 3,483 | 0.0% | 0.11% | -15.4% |
| Q4 2019 | $712,000 | +154.3% | 3,483 | 0.0% | 0.13% | +136.4% |
| Q3 2019 | $280,000 | +18.6% | 3,483 | +39.2% | 0.06% | +31.0% |
| Q2 2019 | $236,000 | +10.3% | 2,503 | 0.0% | 0.04% | +10.5% |
| Q1 2019 | $214,000 | +52.9% | 2,503 | 0.0% | 0.04% | +35.7% |
| Q4 2018 | $140,000 | – | 2,503 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $110,053,269 | 27.64% |
| Ghost Tree Capital, LLC | 500,000 | $18,995,000 | 8.11% |
| First Light Asset Management, LLC | 2,062,453 | $78,352,589 | 7.27% |
| Boxer Capital, LLC | 1,230,004 | $46,727,852 | 2.46% |
| Sofinnova Investments, Inc. | 992,029 | $37,687,182 | 2.24% |
| Tri Locum Partners LP | 141,466 | $5,374,000 | 2.17% |
| MPM BioImpact LLC | 194,181 | $7,376,936 | 1.91% |
| Ikarian Capital, LLC | 201,200 | $7,643,588 | 1.84% |
| KRS Capital Management, LLC | 28,141 | $1,069,077 | 1.46% |
| EMERALD ADVISERS, LLC | 679,772 | $25,824,538 | 1.25% |